These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31075939)

  • 61. Traditional Chinese medicine as targeted treatment for epithelial-mesenchymal transition-induced cancer progression.
    Liu J; Ke F; Cheng H; Zhou J
    J Cell Biochem; 2019 Feb; 120(2):1068-1079. PubMed ID: 30431663
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.
    Rangasamy D; Lenka N; Ohms S; Dahlstrom JE; Blackburn AC; Board PG
    Curr Mol Med; 2015; 15(7):588-97. PubMed ID: 26321759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autocrine Fibronectin Inhibits Breast Cancer Metastasis.
    Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK
    Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance.
    Manzoor S; Muhammad JS; Maghazachi AA; Hamid Q
    Front Oncol; 2022; 12():924290. PubMed ID: 35912261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of EMT Markers SLUG and TWIST in Breast Cancer.
    Grzegrzolka J; Biala M; Wojtyra P; Kobierzycki C; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2015 Jul; 35(7):3961-8. PubMed ID: 26124343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.
    Steven A; Seliger B
    Breast Care (Basel); 2018 Mar; 13(1):16-21. PubMed ID: 29950962
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer.
    Sun X; Wang M; Wang M; Yao L; Li X; Dong H; Li M; Li X; Liu X; Xu Y
    Front Cell Dev Biol; 2020; 8():655. PubMed ID: 32793598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment.
    D'Angelo E; Lindoso RS; Sensi F; Pucciarelli S; Bussolati B; Agostini M; Collino F
    Front Oncol; 2020; 10():1122. PubMed ID: 32793478
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model.
    Tobe-Nishimoto A; Morita Y; Nishimura J; Kitahira Y; Takayama S; Kishimoto S; Matsumiya-Matsumoto Y; Matsunaga K; Imai T; Uzawa N
    Clin Exp Metastasis; 2024 Aug; ():. PubMed ID: 39126553
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential.
    Cao Y; Chen E; Wang X; Song J; Zhang H; Chen X
    Cancer Cell Int; 2023 Feb; 23(1):20. PubMed ID: 36750864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis.
    Hayashida T; Jinno H; Kitagawa Y; Kitajima M
    J Oncol; 2011; 2011():591427. PubMed ID: 21253528
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interplay between tumor microenvironment and partial EMT as the driver of tumor progression.
    Aggarwal V; Montoya CA; Donnenberg VS; Sant S
    iScience; 2021 Feb; 24(2):102113. PubMed ID: 33659878
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Do Tumor Mechanical Stresses Promote Cancer Immune Escape?
    Onwudiwe K; Najera J; Siri S; Datta M
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497097
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of stromal cells in epithelial-mesenchymal plasticity and its therapeutic potential.
    Wang J; Peng J; Chen Y; Nasser MI; Qin H
    Discov Oncol; 2024 Jan; 15(1):13. PubMed ID: 38244071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of Glycans in Cancer Cells Undergoing Epithelial-Mesenchymal Transition.
    Li X; Wang X; Tan Z; Chen S; Guan F
    Front Oncol; 2016; 6():33. PubMed ID: 26925388
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.
    Heinrich EL; Walser TC; Krysan K; Liclican EL; Grant JL; Rodriguez NL; Dubinett SM
    Cancer Microenviron; 2012 Apr; 5(1):5-18. PubMed ID: 21922183
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
    Wang S; Li Y; Xing C; Ding C; Zhang H; Chen L; You L; Dai M; Zhao Y
    Am J Cancer Res; 2020; 10(7):1937-1953. PubMed ID: 32774994
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.